CRNX: Crinetics Pharmaceuticals Inc

29.23 USD 0.42 (1.42%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von CRNX hat sich für heute um -1.42% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 28.96 bis zu einem Hoch von 30.15 gehandelt.

Verfolgen Sie die Crinetics Pharmaceuticals Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

CRNX News

Investing 11:01 Crinetics’ 48% decline validates InvestingPro’s October 2024 overvalued call
Investing 14:00 Crinetics stock rating reiterated by Piper Sandler ahead of PALSONIFY PDUFA
Investing 11:40 H.C. Wainwright reiterates Buy rating on Crinetics stock at $81 price target
Investing 17:30 Crinetics stock maintains Buy rating at Jones Trading on positive ENDO’25 data
Investing 09:21 JMP reiterates Market Outperform rating on Crinetics stock as paltusotine shows strong data
Benzinga 18:18 Crinetics Reports Durable Symptom, Hormone Control With Oral Drug In Acromegaly - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Investing 10:08 Goldman Sachs initiates coverage on Crinetics stock with Neutral rating
Investing 18:01 Alibaba, Merck Stir Wednesday’s Market Cap Stock Movers
Investing 08:55 Crinetics stock rating reiterated at Market Outperform by JMP ahead of key data
Investing 11:41 H.C. Wainwright reiterates buy rating on Crinetics stock at $81 target
Investing 12:12 Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
Seeking Alpha 07:54 Crinetics: Highly Priced Biotech Awaits PDUFA On Acromegaly Drug (NASDAQ:CRNX)
Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
Investing 20:44 Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 H.C. Wainwright maintains Crinetics stock Buy rating, $81 target
Investing 12:12 Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
Investing 20:16 Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
Seeking Alpha 18:15 Crinetics Pharma: Strong Progress With Indications And Upcoming PDUFA (NASDAQ:CRNX)
Benzinga 19:56 JP Morgan Survey: 90% Of Endocrinologists Are Aware Of Crinetics' Atumelnant Data - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Benzinga 18:49 Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology - Crinetics Pharmaceuticals (NASDAQ:CRNX)
Benzinga 14:50 This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Avalo Therapeutics (NASDAQ:AVTX), Assembly Biosciences (NASDAQ:ASMB)

Tagesspanne

28.96 30.15

Jahresspanne

24.10 62.53

Vorheriger Schlusskurs: 29.27
Eröffnung: 29.65

Bid: 29.23
Ask: 29.53

Tief: 28.96
Hoch: 30.15

Volumen: 2.159 K

Tagesänderung: -1.42%
Monatsänderung: 1.67%

6-Monatsänderung: -25.94%
Jahresänderung: -46.26%

30 Juli, Mittwoch